title: FIXED DOSE COMBINATIONS WITH SELECTIVE BETA-BLOCKERS: QUANTITATIVE DETERMINATION IN BIOLOGICAL FLUIDS.
abstract: Hypertension is one of the most common causes of death, a complex and incompletely controlled disease for millions of patients. Metoprolol, bisoprolol, nebivolol and atenolol are selective beta-blockers frequently used in the management of arterial hypertension, alone or in fixed combination with other substances. This study presents the most used analytical methods for simultaneous determination in biological fluids of fixed combinations containing selective beta-blockers. Articles in Pub-Med, Science Direct and Wiley Journals databases published between years 2004-2014 were reviewed. Methods such as liquid chromatography--mass spectrometry--mass spectrometry (LC-MS/MS), high performance liquid chromatography (HPLC) or high performance liquid chromatography--mass spectrometry (HPLC-MS) were used for determination of fixed combination with beta-blockers in human plasma, rat plasma and human breast milk. LC-MS/MS method was used for simultaneous determination of fixed combinations of metoprolol with simvastatin, hydrochlorothiazide or ramipril, combinations of nebivolol and valsartan, or atenolol and amlodipine. Biological samples were processed by protein precipitation techniques or by liquid-liquid extraction. For the determination of fixed dose combinations of felodipine and metoprolol in rat plasma liquid chromatography--electrospray ionization--mass spectrometry (LC-ESI-MS/MS) was applied, using phenacetin as internal standard. HPLC-MS method was applied for the determination of bisoprolol and hydrochlorothiazide in human plasma. For the determination of atenolol and chlorthalidone from human breast milk and human plasma the HPLC method was used. The analytical methods were validated according to the specialized guidelines, and were applied to biological samples, thing that confirms the permanent concern of researchers in this field.
authors.forename: Ştefania Corina
authors.initials: ŞC
authors.lastname: Mahu
authors.forename: Monica
authors.initials: M
authors.lastname: Hăncianu
authors.forename: Luminiţa
authors.initials: L
authors.lastname: Agoroaei
authors.forename: Ioana Cezara
authors.initials: IC
authors.lastname: Grigoriu
authors.forename: Anca Monica
authors.initials: AM
authors.lastname: Strugaru
authors.forename: Elena
authors.initials: E
authors.lastname: Butnaru
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000493:pharmacokinetics*; D000818:Animals; D000959:Antihypertensive Agents / Q000493:pharmacokinetics; D001262:Atenolol / Q000493:pharmacokinetics; D001578:Benzopyrans / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D002853:Chromatography, Liquid / Q000379:methods; D004232:Diuretics / Q000493:pharmacokinetics; D004338:Drug Combinations; D004983:Ethanolamines / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000493:pharmacokinetics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics; D006973:Hypertension / Q000188:drug therapy; D013058:Mass Spectrometry / Q000379:methods; D008790:Metoprolol / Q000493:pharmacokinetics; D008895:Milk, Human / Q000737:chemistry*; D000068577:Nebivolol; D010949:Plasma / Q000737:chemistry*; D017257:Ramipril / Q000493:pharmacokinetics; D051381:Rats; D015203:Reproducibility of Results; D019821:Simvastatin / Q000493:pharmacokinetics; D053719:Tandem Mass Spectrometry / Q000379:methods; D013777:Tetrazoles / Q000493:pharmacokinetics; D014633:Valine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D000068756:Valsartan
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001578:Benzopyrans; D004232:Diuretics; D004338:Drug Combinations; D004983:Ethanolamines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013777:Tetrazoles; D000068577:Nebivolol; D006852:Hydrochlorothiazide; D001262:Atenolol; D000068756:Valsartan; D019821:Simvastatin; D008790:Metoprolol; D014633:Valine; D017257:Ramipril